ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

In Brief: ACCC to Bid On Ovarian Cancer Treatment RFP; Community MDs Handle 90% Of Ovarian Patients

September 5, 1975

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986